Q4 2022 Holdings
Filed 2023-02-09 | 7 holdings | $48.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crispr Therapeutics AG(CRSP) | Common Shares | H17182108 | $20.3M | 498,558 | 41.9% |
| Gritstone Oncology, Inc.(2JQ) | Common Stock | 39868T105 | $12.3M | 3,561,150 | 25.4% |
| Passage Bio, Inc. | Common Stock | 702712100 | $6.8M | 4,959,769 | 14.2% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $3.4M | 543,753 | 7.1% |
| Adverum Biotechnologies, Inc.(ADVMCHF) | Common Stock | 00773U108 | $2.9M | 5,068,233 | 6.1% |
| Aligos Therapeutics, Inc. | Common Stock | 01626L105 | $2.2M | 2,320,381 | 4.6% |
| Minerva Surgical Inc. | Common Stock | 60343F106 | $373.9K | 1,673,700 | 0.8% |